Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 1996 Mar 5;93(5):2186-91.
doi: 10.1073/pnas.93.5.2186.

Peptides from conserved regions of paramyxovirus fusion (F) proteins are potent inhibitors of viral fusion

Affiliations
Comparative Study

Peptides from conserved regions of paramyxovirus fusion (F) proteins are potent inhibitors of viral fusion

D M Lambert et al. Proc Natl Acad Sci U S A. .

Abstract

The synthetic peptides DP-107 and DP-178 (T-20), derived from separate domains within the human immunodeficiency virus type 1 (HIV-1) transmembrane (TM) protein, gp4l, are stable and potent inhibitors of HIV-1 infection and fusion. Using a computer searching strategy (computerized antiviral searching technology, C.A.S.T.) based on the predicted secondary structure of DP-107 and DP-178 (T-20), we have identified conserved heptad repeat domains analogous to the DP-107 and DP-178 regions of HIV-1 gp41 within the glycoproteins of other fusogenic viruses. Here we report on antiviral peptides derived from three representative paramyxoviruses, respiratory syncytial virus (RSV), human parainfluenza virus type 3 (HPIV-3), and measles virus (MV). We screened crude preparations of synthetic 35-residue peptides, scanning the DP-178-like domains, in antiviral assays. Peptide preparations demonstrating antiviral activity were purified and tested for their ability to block syncytium formation. Representative DP-178-like peptides from each paramyxovirus blocked homologous virus-mediated syncytium formation and exhibited EC50 values in the range 0.015-0.250 microM. Moreover, these peptides were highly selective for the virus of origin. Identification of biologically active peptides derived from domains within paramyxovirus F1 proteins analogous to the DP-178 domain of HIV-1 gp4l is compelling evidence for equivalent structural and functional features between retroviral and paramyxoviral fusion proteins. These antiviral peptides provide a novel approach to the development of targeted therapies for paramyxovirus infections.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Virology. 1974 Feb;57(2):475-90 - PubMed
    1. Immunol Rev. 1994 Aug;140:93-104 - PubMed
    1. Int J Pept Protein Res. 1978 Mar;11(3):246-9 - PubMed
    1. Methods Biochem Anal. 1985;31:61-163 - PubMed
    1. Science. 1985 Sep 27;229(4720):1402-5 - PubMed

Publication types

LinkOut - more resources